International Journal of Infectious Diseases (Jun 2018)

HIV viral suppression in Oman: Encouraging progress toward achieving the United Nations ‘third 90’

  • Ali Elgalib,
  • Samir Shah,
  • Zeyana Al-Habsi,
  • Maha Al-Fouri,
  • Halima Al-Sawafi,
  • Jalila Al-Noumani,
  • Adil Al-Baloushi,
  • Saad Al-Alawi,
  • Salma Al-Badi,
  • Zainab Mohammed,
  • Jokha Al-Ghafri,
  • Asma Suleimani,
  • Huda Al-Mashani,
  • Jyothish Raju,
  • Saada Al-Riyami,
  • Muna Al-Shukri,
  • Abdul Wahab,
  • Bilal Hussain,
  • Khalifa Al-Naabi,
  • Anantha Narayan,
  • Noreen Oliveros,
  • George Prasad,
  • Ahmed Hussein,
  • Rajeev Kashyp,
  • Khalid Al-Shardi,
  • Ahmed Nada,
  • Shakil Akhwand,
  • Bina Kamble,
  • Kawthar Al-Aamri,
  • Suad Al-Mukhaini,
  • Hanan Al-Kindi,
  • Faryal Khamis,
  • Amal Al-Maani,
  • Idris Al-Abaidani,
  • Seif Al-Abri

DOI
https://doi.org/10.1016/j.ijid.2018.04.795
Journal volume & issue
Vol. 71, no. C
pp. 94 – 99

Abstract

Read online

Objective: To assess the impact of capacity-building interventions introduced by the Oman National AIDS Programme on the quality of HIV care in the country. Methods: HIV viral load (VL) suppression and loss to follow-up (LTFU) rates were calculated for the period before (in December 2015; n = 1098) and after (in June 2017; n = 1185) the introduction of the interventions: training, support, and care pathway development. Three HIV VL cuts-offs at last measurement in the year of interest were used to define VL suppression. Results: In the intention-to-treat (ITT) analysis, rates of VL <200 copies/ml and <1000 copies/ml increased from 51.9% in 2015 to 65.5% in 2017 (relative risk (RR) 1.26, 95% confidence interval (CI) 1.17–1.36) and from 58.1% in 2015 to 70.9% in 2017 (RR 1.22, 95% CI 1.14–1.30), respectively; p < 0.0001 for both. Similarly, in the on-treatment analysis, rates of VL <200 copies/ml and <1000 copies/ml increased from 64.2% in 2015 to 76.9% in 2017 (RR 1.20, 95% CI 1.12–1.28) and from 71.9% in 2015 to 83.2% in 2017 (RR 1.16, 95% CI 1.10–1.22), respectively. Fewer patients were LTFU in 2017 than in 2015 (14.7% (157/1061) vs. 19.2% (188/981); RR 0.77, 95% CI 0.64–0.94). Conclusions: Achieving the UNAIDS target of 90% of HIV patients on treatment having VL suppression by 2020 is feasible in Oman.

Keywords